Kepler Cheuvreux Downgrades Valerio Therapeutics (ALVIO:FP) to ReduceKepler Cheuvreux analyst Christophe Dombu downgraded Valerio Therapeutics (ALVIO:FP) from Hold to Reduce with a price target of EUR0.01 (from EUR0.10).
Kepler Cheuvreux Downgrades Valerio Therapeutics (ALVIO:FP) to ReduceKepler Cheuvreux analyst Christophe Dombu downgraded Valerio Therapeutics (ALVIO:FP) from Hold to Reduce with a price target of EUR0.01 (from EUR0.10).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +0.63% per trade.
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -7.03% per trade.
Copying Christophe dombu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -63.43% per trade.
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -69.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ALVIO Analyst Recommendation Trends
Rating
Oct 24
Feb 25
Aug 25
Oct 25
Nov 25
Strong Buy
3
1
0
0
0
Buy
0
0
0
0
0
Hold
1
1
4
9
15
Sell
0
0
0
0
0
Strong Sell
0
1
1
1
0
total
4
3
5
10
15
In the current month, ALVIO has received 0Buy Ratings, 15Hold Ratings, and 0Sell Ratings. ALVIO average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
ALVIO Stock Forecast FAQ
What is FR:ALVIO’s average 12-month price target, according to analysts?
Currently, no data Available
What is FR:ALVIO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for FR:ALVIO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Valerio Therapeutics a Buy, Sell or Hold?
Currently, no data Available
What is Valerio Therapeutics’s share price target?
Currently, no data Available
What do analysts say about Valerio Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Valerio Therapeutics?
To buy shares of FR:ALVIO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.